|
|
Levitra Articles
- Tadalafil once daily in the management of erectile dysfunction patient and partner perspectives
- Patient preference and satisfaction in erectile dysfunction therapy a comparison of the three phosphodiesterase-5 inhibitors sildenafil Levitra and tadalafil
- Phosphodiesterase Type 5 Inhibitors and Female Sexual Response Faulty Protocols or Paradigms
- Sexual Risk Behaviors among Men who have Sex with Men Using Erectile Dysfunction Medications
- ACceptance of Therapy In Levitra-treated patients with Erectile dysfunction ACTIVE a noninterventional study in Germany
- Acute Levitra Administration Improves Bladder Oxygenation in Spontaneously Hypertensive Rats
- Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia
- Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction a systematic review and meta-analysis
- Hormonal testing and pharmacologic treatment of erectile dysfunction a clinical practice guideline from the american college of physicians
- Hair analysis to demonstrate administration of sildenafil to a woman in a case of drug-facilitated sexual assault
- Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction preference and adherence to treatment
- Phosphodiesterase type 5 inhibitors unmet needs
- PDE5 inhibitors in vitro and in vivo pharmacological profile
- Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor
- Identification of sildenafil tadalafil and Levitra by gas chromatography-mass spectrometry on short capillary column
- Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction A Clinical Practice Guideline From the American College of Physicians
- Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction A Systematic Review and Meta-analysis
- Pharmacotherapy of the overactive bladder
- The effect of phosphodiesterase isoenzyme 5 inhibitors on ureteropelvic junction obstruction in rabbits
- Gender differences in tail-skin flushing induced by nitrates and phosphodiesterase type 5 inhibitors in a climacteric mouse model
- Gateways to clinical trials
- Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract
- Platelet Cyclic Guanosine Monophosphate as a Biomarker of Phosphodiesterase Type 5 Inhibitor Efficacy in the Treatment of Erectile Dysfunction A Randomized Placebo-Controlled Study
- Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension
- Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver
- Probing the catalytic sites and activation mechanism of photoreceptor phosphodiesterase using radiolabeled phosphodiesterase inhibitors
- 2009 update on phosphodiesterase type 5 inhibitor therapy part 2 updates on optimal utilization for sexual concerns and rare toxicities in this class
- Levitra allows successful intercourse initiated rapidly after dosing in Japanese patients with diabetes mellitus and erectile dysfunction
- Levitra can Improve Continence Recovery after Bilateral Nerve Sparing Prostatectomy Results of a Randomized Double Blind Placebo-Controlled Pilot Study
- Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy longitudinal data from the Erectile Dysfunction Observational Study
- Levitra-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder
- Phosphodiesterase type 5 inhibitors facilitate noncontact erections in male rats site of action in the brain and mechanism of action
- Comparison of Pharmacokinetics of Levitra Administered Using an Ultrasonic Nebulizer for Inhalation vs a Single 10-mg Oral Tablet
- Five-year experience with tadalafil in the UK an effective treatment for erectile dysfunction
- Toward a new 'EPOCH' optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
- The burden and extent of comorbid conditions in patients with erectile dysfunction
- Effect of propionyl-L-carnitine L-arginine and nicotinic acid on the efficacy of Levitra in the treatment of erectile dysfunction in diabetes
- Follicle development and luteal cell morphology altered by phosphodiesterase-5 inhibitor
- Levitra reduces testicular damage following ischemia/reperfusion injury in rats
- 2009 update on phosphodiesterase type 5 inhibitor therapy part 1 Recent studies on routine dosing for penile rehabilitation lower urinary tract symptoms and other indications CME
- The ENDOTRIAL study a spontaneous open-label randomized multicenter crossover study on the efficacy of sildenafil tadalafil and Levitra in the treatment of erectile dysfunction
- Gateways to clinical trials
- Levitra treatment for patients with pulmonary arterial hypertension a multicentre open-label study
- Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil tadalafil and/or Levitra using LC/PDA and extracted ion LC-MS/TOF
- High performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of Levitra sildenafil tadalafil testosterone and local anesthetics in cosmetic creams sold on the Internet web sites
- Gateways to clinical trials
- Levitra protects against myocardial and endothelial injuries after cardiopulmonary bypass
- Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta
- Effects of Levitra administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation
- Levitra modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats